Aralez Pharmaceuticals Inc. News Releases http://ir.aralez.com/ Aralez Pharmaceuticals Inc. News Releases en Aralez Pharmaceuticals Completes Sale of Vimovo Royalties and Canadian Operations to Nuvo Pharmaceuticals http://ir.aralez.com/news-releases/news-release-details/aralez-pharmaceuticals-completes-sale-vimovo-royalties-and MISSISSAUGA, ON , Dec. 31, 2018 /CNW/ - Aralez Pharmaceuticals Inc. (" Aralez " or the " Company ") announced today that it and certain of its affiliates have completed the previously announced sale of its VIMOVO ®  royalties and Canadian operations to Nuvo Pharmaceuticals Inc. Mon, 31 Dec 2018 11:29:00 -0500 Aralez Pharmaceuticals Inc. News Releases 18301 Aralez Pharmaceuticals to Seek Court Approval of Previously Announced "Stalking Horse" Transactions for Substantially All Assets http://ir.aralez.com/news-releases/news-release-details/aralez-pharmaceuticals-seek-court-approval-previously-announced MISSISSAUGA, ON, Nov. 29, 2018 /CNW/ - Aralez Pharmaceuticals Inc. (" Aralez " or the " Company ") announced today that it and certain of its affiliates will seek court approval for the sale of its VIMOVO ®  royalties and Canadian operations to Nuvo Pharmaceuticals Inc. Thu, 29 Nov 2018 09:00:00 -0500 Aralez Pharmaceuticals Inc. News Releases 18291 Aralez Pharmaceuticals Enters Into Definitive "Stalking Horse" Purchase Agreements For Substantially All Assets http://ir.aralez.com/news-releases/news-release-details/aralez-pharmaceuticals-enters-definitive-stalking-horse-purchase Transactions valued at an aggregate of U.S. $240 million MISSISSAUGA, Ontario, Sept. 19, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (" Aralez " or the " Company ") announced today that it and certain of its affiliates have entered into purchase agreements with two separate stalking-horse Wed, 19 Sep 2018 06:54:00 -0400 Aralez Pharmaceuticals Inc. News Releases 18261 Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets http://ir.aralez.com/news-releases/news-release-details/aralez-pharmaceuticals-enter-purchase-agreements-sell Transactions to be valued at an aggregate of U.S. $250 million Commences Voluntary Proceedings under CCAA in Canada and Chapter 11 in the United States Company to Continue Operating Business and Serving Customers As Usual MISSISSAUGA, Ontario , Aug. 10, 2018 /CNW/ --  Aralez Pharmaceuticals Inc. Fri, 10 Aug 2018 06:00:00 -0400 Aralez Pharmaceuticals Inc. News Releases 18246 Aralez Enters Into Amendment To Second Amended And Restated Facility Agreement http://ir.aralez.com/news-releases/news-release-details/aralez-enters-amendment-second-amended-and-restated-facility MISSISSAUGA, Ontario , June 29, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) (" Aralez " or the " Company ") today announced that, in connection with its review of strategic alternatives, it entered into an Amendment (the " Amendment ") to that certain Second Amended Fri, 29 Jun 2018 18:10:00 -0400 Aralez Pharmaceuticals Inc. News Releases 18231 Aralez Announces Voting Results From 2018 Annual Meeting Of Shareholders http://ir.aralez.com/news-releases/news-release-details/aralez-announces-voting-results-2018-annual-meeting-shareholders MISSISSAUGA, Ontario , June 29, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc.  (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced the results of the matters voted upon at the Company's 2018 annual meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") Fri, 29 Jun 2018 18:10:00 -0400 Aralez Pharmaceuticals Inc. News Releases 18221 Aralez Announces First Quarter 2018 Financial Results http://ir.aralez.com/news-releases/news-release-details/aralez-announces-first-quarter-2018-financial-results-0 -1Q 2018 Net Revenues Increased to $38.1 Million Versus $26.0 Million in 1Q 2017- MISSISSAUGA, Ontario , May 8, 2018 /PRNewswire/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) (" Aralez " or the " Company ") today announced financial results for the first quarter ending March 31, 2018 . Tue, 08 May 2018 06:57:45 -0400 Aralez Pharmaceuticals Inc. News Releases 18146 Aralez Announces New Strategic Direction http://ir.aralez.com/news-releases/news-release-details/aralez-announces-new-strategic-direction -Focus on Canadian Operations, supported by Toprol-XL® Franchise Revenues and Vimovo® Royalties- -Discontinuation of U.S. Commercial Operations, with Significant Reductions in Operating Expenses- -Actively Exploring Strategic Alternatives for Business- MISSISSAUGA, Ontario , May 8, 2018 Tue, 08 May 2018 06:55:00 -0400 Aralez Pharmaceuticals Inc. News Releases 18096 Aralez To Announce First Quarter 2018 Results On May 8, 2018 http://ir.aralez.com/news-releases/news-release-details/aralez-announce-first-quarter-2018-results-may-8-2018 -Executive Management to Host Conference Call on May 8, 2018 at 8:00 a.m. ET - MISSISSAUGA, Ontario , April 27, 2018 /CNW/ --  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) today announced that it will report its first quarter 2018 financial results on Tuesday, May 8, 2018 , before the Fri, 27 Apr 2018 07:00:00 -0400 Aralez Pharmaceuticals Inc. News Releases 18071 Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results http://ir.aralez.com/news-releases/news-release-details/aralez-announces-fourth-quarter-and-full-year-2017-financial -4Q 2017 Net Revenues Increased to $28.0 Million Versus $20.0 Million in the 4Q 2016- -Full-Year Net Revenues Increased to $105.9 Million Versus $54.3 Million in Full-Year 2016- -Provides 2018 Full-Year Financial Guidance- MISSISSAUGA, Ontario , March 13, 2018 /PRNewswire/ -- Aralez Pharmaceuticals Tue, 13 Mar 2018 07:00:00 -0400 Aralez Pharmaceuticals Inc. News Releases 17986